Free Trial
NASDAQ:APDN

Applied DNA Sciences Q3 2025 Earnings Report

Applied DNA Sciences logo
$3.14 -0.11 (-3.23%)
As of 03:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Applied DNA Sciences EPS Results

Actual EPS
-$34.00
Consensus EPS
-$37.50
Beat/Miss
Beat by +$3.50
One Year Ago EPS
N/A

Applied DNA Sciences Revenue Results

Actual Revenue
$0.30 million
Expected Revenue
$1.28 million
Beat/Miss
Missed by -$976.00 thousand
YoY Revenue Growth
N/A

Applied DNA Sciences Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Thursday, August 14, 2025
Conference Call Time
4:00PM ET

Applied DNA Sciences Earnings Headlines

Earnings Scheduled For August 26, 2025
Applied DNA Sciences Focuses on LineaRx for Growth
Why More Investors Are Using Family Trusts to Protect Their Wealth
For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026. If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest.tc pixel
Applied DNA Sciences Regains Nasdaq Compliance
Applied DNA Sciences, Inc. (APDN) - Yahoo Finance
APDN - Applied DNA Sciences Inc News - Morningstar
See More Applied DNA Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Applied DNA Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Applied DNA Sciences and other key companies, straight to your email.

About Applied DNA Sciences

Applied DNA Sciences (NASDAQ:APDN), Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

View Applied DNA Sciences Profile

More Earnings Resources from MarketBeat